|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 90 studies with search of: | Abacavir sulfate/Lamivudine OR Epzicom[TREATMENT] AND HIV [CONDITION] |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Active, not recruiting |
Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects
|
||||
| 2 | Active, not recruiting |
A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT
|
||||
| 3 | Completed |
Pharmacokinetic Study Of EPZICOM Tablet
|
||||
| 4 | Recruiting |
Safety and Efficacy Study of Switching From Epzicom to Truvada
|
||||
| 5 | Recruiting |
Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment
|
||||
| 6 | Recruiting |
Artery Elasticity After Switch From Epzicom to Truvada
|
||||
| 7 |
Completed Has Results |
Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV
|
||||
| 8 | Active, not recruiting |
A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination
|
||||
| 9 | Recruiting |
A Randomised, Open-Label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-Emtricitabine or Abacavir-Lamivudine: The STEAL Study
|
||||
| 10 | Not yet recruiting |
Raltegravir + ABC/3TC in HIV/TB Co-Infected Patients
|
||||
| 11 | Completed |
KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks
|
||||
| 12 | Active, not recruiting |
Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection
|
||||
| 13 | Completed |
A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients
|
||||
| 14 | Completed |
New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects
|
||||
| 15 | Active, not recruiting |
Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment
|
||||
| 16 | Active, not recruiting |
HIV Treatment and CVD Events
|
||||
| 17 | Recruiting |
Clinical Trial of CNS-targeted HAART (CIT2)
|
||||
| 18 | Active, not recruiting |
Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment
|
||||
| 19 | Completed |
A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults
|
||||
| 20 | Active, not recruiting |
Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
|